These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 14975520)

  • 41. Combination of bupropion, paroxetine and quetiapine as adjuvant treatment for multiple myeloma.
    Kast RE; Altschuler EL
    Med Hypotheses; 2004; 62(5):817-8. PubMed ID: 15082113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatopulmonory syndrome--an uncommon and severe complication of certain liver diseases.
    Sarkar P; Basu AK; Mandal SK; Basu D; Banerjee R; Pal SK; Bandopadhyay D; Chakraborty N
    J Indian Med Assoc; 2005 Sep; 103(9):469-70, 472. PubMed ID: 16493866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhaled nitric oxide improves the hepatopulmonary syndrome: a physiologic analysis.
    Gupta S; Tang R; Al-Hesayen A
    Thorax; 2021 Nov; 76(11):1142-1145. PubMed ID: 33859047
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A case of hepatopulmonary syndrome solved by mycophenolate mofetil (an inhibitor of angiogenesis and nitric oxide production).
    Moreira Silva H; Reis G; Guedes M; Cleto E; Vizcaíno JR; Kelly D; Gennery AR; Santos Silva E
    J Hepatol; 2013 Mar; 58(3):630-3. PubMed ID: 23104163
    [No Abstract]   [Full Text] [Related]  

  • 45. The hepatopulmonary syndrome: NO way out?
    Dinh-Xuan AT; Naeije R
    Eur Respir J; 2004 May; 23(5):661-2. PubMed ID: 15176675
    [No Abstract]   [Full Text] [Related]  

  • 46. The successful use of inhaled nitric oxide in the management of severe hepatopulmonary syndrome after orthotopic liver transplantation.
    Santos J; Young P; Barjaktarevic I; Lazar C; Susanto I; Wang T
    Case Reports Hepatol; 2014; 2014():415109. PubMed ID: 25374726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of an NO-synthase inhibitor L-NMMA in the hepatopulmonary syndrome.
    Maniscalco M; Sofia M; Higenbottam T
    Respiration; 2001; 68(2):226. PubMed ID: 11287843
    [No Abstract]   [Full Text] [Related]  

  • 48. Cardiopulmonary effects of nitric oxide inhalation and methylene blue injection in hepatopulmonary syndrome.
    Jounieaux V; Leleu O; Mayeux I
    Intensive Care Med; 2001 Jun; 27(6):1103-4. PubMed ID: 11497151
    [No Abstract]   [Full Text] [Related]  

  • 49. Methylene blue improves the hepatopulmonary syndrome.
    Groneberg DA; Fischer A
    Ann Intern Med; 2001 Sep; 135(5):380-1. PubMed ID: 11529704
    [No Abstract]   [Full Text] [Related]  

  • 50. Is nitric oxide the ultimate mediator in hepatopulmonary syndrome?
    Rolla G
    J Hepatol; 2003 May; 38(5):668-70. PubMed ID: 12713879
    [No Abstract]   [Full Text] [Related]  

  • 51. Possible confusion of Paxil and paclitaxel.
    Hoy RH
    Am J Hosp Pharm; 1993 Jun; 50(6):1137. PubMed ID: 8100118
    [No Abstract]   [Full Text] [Related]  

  • 52. Do Late Bubbles Correspond to Early Hepatopulmonary Syndrome?
    DuBrock HM; J Krowka M
    Ann Hepatol; 2017; 16(4):476-477. PubMed ID: 28612753
    [No Abstract]   [Full Text] [Related]  

  • 53. Hepatopulmonary Syndrome and Liver Transplantation.
    Krowka M
    Liver Transpl; 2000 Jan; 6(1):113-115. PubMed ID: 10648589
    [No Abstract]   [Full Text] [Related]  

  • 54. A case of paroxetine-induced antidepressant discontinuation syndrome related to pregnancy: time to redefine the syndrome?
    Javelot H; Fichter A; Meyer G; Michel B; Hingray C
    Psychiatry Res; 2020 Sep; 291():113259. PubMed ID: 32619827
    [No Abstract]   [Full Text] [Related]  

  • 55. Hepatopulmonary syndrome.
    Gadour MO; Ayoola A; Yousuf AZ; El Sammani el Tel W
    Saudi J Gastroenterol; 2001 Sep; 7(3):85-94. PubMed ID: 19861775
    [No Abstract]   [Full Text] [Related]  

  • 56. Hepatopulmonary Syndrome.
    Lv Y; Fan D
    Dig Dis Sci; 2015 Jul; 60(7):1914-23. PubMed ID: 25732713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NMDA receptor/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test.
    Ghasemi M; Montaser-Kouhsari L; Shafaroodi H; Nezami BG; Ebrahimi F; Dehpour AR
    Psychopharmacology (Berl); 2009 Oct; 206(2):325-33. PubMed ID: 19609507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paroxetine for hepatopulmonary syndrome?
    Altschuler EL; Kast RE
    Med Hypotheses; 2004; 62(3):446-7. PubMed ID: 14975520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A severe (type II) hepatopulmonary syndrome in a patient with idiopathic portal hypertension and treatment with paroxetine.
    Yilmaz S; Dursum M; Canoruç F; Bayan K; Karabulut A; Akay H
    Neth J Med; 2005 Dec; 63(11):448-52. PubMed ID: 16397315
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat.
    Ling Y; Zhang J; Luo B; Song D; Liu L; Tang L; Stockard CR; Grizzle WE; Ku DD; Fallon MB
    Hepatology; 2004 Jun; 39(6):1593-602. PubMed ID: 15185300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.